Biomedical applications of hyaluronic acid-based nanomaterials in hyperthermic cancer therapy

30Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Hyaluronic acid (HA) is a non-sulfated polysaccharide polymer with the properties of biodegradability, biocompatibility, and non-toxicity. Additionally, HA specifically binds to certain receptors that are over-expressed in cancer cells. To maximize the effect of drug delivery and cancer treatment, diverse types of nanomaterials have been developed. HA-based nanomaterials, including micelles, polymersomes, hydrogels, and nanoparticles, play a critical role in efficient drug delivery and cancer treatment. Hyperthermic cancer treatment using HA-based nanomaterials has attracted attention as an efficient cancer treatment approach. In this paper, the biomedical applications of HA-based nanomaterials in hyperthermic cancer treatment and combined therapies are summarized. HA-based nanomaterials may become a representative platform in hyperthermic cancer treatment.

Cite

CITATION STYLE

APA

Kim, S., Moon, M. J., Surendran, S. P., & Jeong, Y. Y. (2019, July 1). Biomedical applications of hyaluronic acid-based nanomaterials in hyperthermic cancer therapy. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics11070306

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free